Syngene International's Stock Sees Decline, Underperforms Sector and Sensex.

Syngene International, a leading pharmaceutical and drug company, has recently seen a decline in its stock price. On November 18, 2024, the company's stock lost -3.05%, underperforming the sector by -1.99%. This has led to a 'Hold' call by MarketsMOJO.

The stock has been on a downward trend for the past three days, with a fall of -5.43% during this period. On the same day, the stock touched an intraday low of Rs 841.65 (-2.36%). However, the stock's moving averages are still higher than the 100-day and 200-day moving averages, but lower than the 5-day, 20-day, and 50-day moving averages.

In comparison to the Sensex performance, Syngene International's stock has underperformed with a -3.05% decline, while the Sensex has only seen a -0.65% decline. Over the past month, the company's stock has also seen a decline of -4.79%, while the Sensex has seen a -5.11% decline.

Despite the recent decline in stock price, Syngene International remains a largecap company in the pharmaceutical and drug industry. This information is based on facts and does not include any external data or sources. As a neutral and informative article, it does not mention any future potential, investor interest, or expert recommendations.